Glomerulonephritis, Membranoproliferative
"Glomerulonephritis, Membranoproliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.
Descriptor ID |
D015432
|
MeSH Number(s) |
C12.777.419.570.363.615 C13.351.968.419.570.363.615 C20.425
|
Concept/Terms |
Glomerulonephritis, Membranoproliferative- Glomerulonephritis, Membranoproliferative
- Glomerulonephritides, Membranoproliferative
- Membranoproliferative Glomerulonephritides
- Glomerulonephritis, Mesangiocapillary
- Glomerulonephritides, Mesangiocapillary
- Mesangiocapillary Glomerulonephritides
- MPGN
- Membranoproliferative Glomerulonephritis
- Mesangiocapillary Glomerulonephritis
- Glomerulonephritis, Hypocomplementemic
- Glomerulonephritides, Hypocomplementemic
- Hypocomplementemic Glomerulonephritides
- Hypocomplementemic Glomerulonephritis
Membranoproliferative Glomerulonephritis, Type I- Membranoproliferative Glomerulonephritis, Type I
- Subendothelial Membranoproliferative Glomerulonephritis
- Membranoproliferative Glomerulonephritis, Subendothelial
- Mesangiocapillary Glomerulonephritis, Type I
|
Below are MeSH descriptors whose meaning is more general than "Glomerulonephritis, Membranoproliferative".
Below are MeSH descriptors whose meaning is more specific than "Glomerulonephritis, Membranoproliferative".
This graph shows the total number of publications written about "Glomerulonephritis, Membranoproliferative" by people in this website by year, and whether "Glomerulonephritis, Membranoproliferative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2017 | 3 | 1 | 4 |
2018 | 3 | 0 | 3 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glomerulonephritis, Membranoproliferative" by people in Profiles.
-
Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection. Pediatr Infect Dis J. 2020 08; 39(8):e206-e207.
-
[COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab]. Nefrologia (Engl Ed). 2021 May-Jun; 41(3):354-356.
-
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece. Medicina (Kaunas). 2020 Jul 17; 56(7).
-
Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN. Front Immunol. 2018; 9:2329.
-
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int. 2018 07; 94(1):199-205.
-
C3-glomerulopathy and MGUS: the skin beyond the kidney. QJM. 2018 Mar 01; 111(3):187-188.
-
Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. Hepatology. 2018 02; 67(2):492-504.
-
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. J Am Soc Nephrol. 2018 01; 29(1):283-294.
-
Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement. Semin Nephrol. 2017 09; 37(5):447-463.
-
Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN. J Am Soc Nephrol. 2017 May; 28(5):1603-1613.